Biogen (BIIB)

EBITDA Margin

19.66%

TTM · Period ending:

BIIB logo

BIIB EBITDA Margin

Latest reported19.66%
BIIB TTM EBITDA Margin (-310.26% → 19.66%)
High-resolution chart · PNG

BIIB ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Biogen EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
19.6614%
26.5283%
29.1379%
34.985%
33.8211%
33.0019%
32.6006%
31.8907%
28.3809%
26.1541%
24.1673%
25.424%
30.9943%
33.4669%
34.7662%
33.6296%
32.8647%
28.4126%
30.7448%
22.3098%
23.0267%
33.0824%
37.8814%
50.0172%
55.3761%
55.488%
53.8584%
54.3916%
54.5111%
51.0897%
52.1427%
51.8173%
52.2707%
53.9141%
53.9942%
55.0997%
53.643%
55.5551%
55.9045%
54.7656%
54.749%
53.7858%
52.1689%
51.9916%
51.0712%
49.7322%
47.9821%
46.2322%
44.4426%
43.6352%
43.9915%
42.9513%
42.4964%
41.6777%
40.2629%
40.3945%
42.4843%
42.1083%
45.7104%
45.7508%
38.4713%
38.3466%
34.3513%
35.8373%
40.6756%
39.0767%
41.0418%
40.9679%
40.5292%
42.4153%
41.631%
42.267%
40.649%
40.9346%
41.3608%
53.5202%
57.5621%
42.8416%
46.4437%
42.2863%
35.5076%
46.8543%
38.9846%
36.5111%
41.1067%
40.0966%
32.7371%
-56.5182%
-94.8373%
-185.657%
-1,246.9443%
42.5554%
34.6506%
32.4373%
30.1414%
32.7063%
38.4555%
40.3367%
41.5277%
43.7595%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.